GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Humana Inc (NYSE:HUM) » Definitions » Peter Lynch Fair Value

HUM (Humana) Peter Lynch Fair Value : N/A (As of Oct. 31, 2024)


View and export this data going back to 1971. Start your Free Trial

What is Humana Peter Lynch Fair Value?

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.


The historical rank and industry rank for Humana's Peter Lynch Fair Value or its related term are showing as below:


During the past 13 years, the highest Price to Peter Lynch Fair Value Ratio of Humana was 5.72. The lowest was 0.44. And the median was 1.84.


HUM's Price-to-Peter-Lynch-Fair-Value is not ranked *
in the Healthcare Plans industry.
Industry Median: 0.93
* Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.

Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.


Humana Peter Lynch Fair Value Historical Data

The historical data trend for Humana's Peter Lynch Fair Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Humana Peter Lynch Fair Value Chart

Humana Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Peter Lynch Fair Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 168.72 807.85 373.34 279.07 243.18

Humana Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Peter Lynch Fair Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 346.31 243.18 133.14 - -

Competitive Comparison of Humana's Peter Lynch Fair Value

For the Healthcare Plans subindustry, Humana's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Humana's Price-to-Peter-Lynch-Fair-Value Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Humana's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:

* The bar in red indicates where Humana's Price-to-Peter-Lynch-Fair-Value falls into.



Humana Peter Lynch Fair Value Calculation

Humana's Peter Lynch Fair Value for today is calculated as

Peter Lynch Fair Value=PEG Ratio*5-Year TTM EBITDA Growth Rate***EPS without NRI (TTM)
=1* N/A *15.78
=N/A

Humana's EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $15.78.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.

If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.

If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.


Humana  (NYSE:HUM) Peter Lynch Fair Value Explanation

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.

Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.

Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 0 instead of 15 in this case.

Humana's Price to Peter Lynch Fair Value Ratio for today is calculated as

Price to Peter Lynch Fair Value=Share Price/Peter Lynch Fair Value
=257.83/N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Humana Peter Lynch Fair Value Related Terms

Thank you for viewing the detailed overview of Humana's Peter Lynch Fair Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Humana Business Description

Address
500 West Main Street, Louisville, KY, USA, 40202
Humana is one of the largest private health insurers in the us with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Executives
Jorge S. Mesquita director C/O KRAFT FOODS INC., THREE LAKES DRIVE, NORTHFIELD IL 60093
Susan M Diamond officer: Segment President, Home Bus. 500 W MAIN ST., LOUISVILLE KY 40202
Sanjay K Shetty officer: President, CenterWell 500 W. MAIN STREET, LOUISVILLE KY 40202
George Ii Renaudin officer: President, Medicare & Medicaid 500 W. MAIN SREET, LOUISVILLE KY 40202
Jones David A Jr/ky director C/O HUMANA INC, 500 WEST MAIN STREET, LOUISVILLE KY 40202
Timothy S. Huval officer: Sr. Vice Pres & Chief HR Offic 500 W. MAIN STREET, LOUISVILLE KY 40202
Bruce D Broussard officer: President 500 W. MAIN STREET, C/O HUMANA LAW DEPT., LOUISVILLE KY 40202
Joseph C Ventura officer: Chief Legal Officer & Corp Sec 500 W MAIN STREET, LOUISVILLE KY 40202
William Kevin Fleming officer: President, Hlthcare Svc Sgmt 500 WEST MAIN STREET, LOUISVILLE KY 40202
Timothy Alan Wheatley officer: President, Retail Segment 500 WEST MAIN STREET, LOUISVILLE KY 40202
Samir Deshpande officer: Chief Risk Officer 500 W MAIN STREET, LOUISVILLE KY 40202
Brad D Smith director 1040 13TH AVE, HUNTINGTON WV 25701
John-paul W. Felter officer: SVP, Chief Accting Off & Cont. 500 W MAIN ST, LOUISVILLE KY 40202
Michael A. Koeberlein officer: SVP, Chief Accting Off & Cont. 500 W MAIN ST., LOUISVILLE KY 40202
David T Feinberg director 1299 OCEAN AVENUE, SUITE 1000, SANTA MONICA CA 90401